News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Vinod Balachandran received OncoDaily’s Yvonne Award in the Breakthrough Research category – Memorial Sloan Kettering Cancer Centre
Photo taken from Memorial Sloan Kettering Cancer Centre/X
Jun 4, 2024, 10:15

Vinod Balachandran received OncoDaily’s Yvonne Award in the Breakthrough Research category – Memorial Sloan Kettering Cancer Centre

Memorial Sloan Kettering Cancer Centre shared a post on X:

“Congratulations to Vinod Balachandran for receiving OncoDaily’s Yvonne Award in the Breakthrough Research category during the 2024 ASCO Annual Meeting.

Learn more here.”

Source: Memorial Sloan Kettering Cancer Centre/X

 

 

2024 Yvonne Award ASCO ASCO24 cancer Memorial Sloan Kettering Cancer Centre OncoDaily Oncology Vinod Balachandran Yvonne Award Yvonne24
Societies
Jul 3, 2024, 06:03
Is de-escalation of adjuvant treatment safe in stage I HER2+ tumors larger than 1 cm?
Societies
Jul 3, 2024, 05:47
Keynote lecture on liver cancer by Stephen L Chan
Blog
Jul 3, 2024, 04:18
FDA and WHOSTP discuss increasing clinical trials access and lowering barriers to participation
Blog
Jul 3, 2024, 04:02
Sachin H. Jain: Our broken culture of communications
Insight
Jul 3, 2024, 03:34
Anirban Maitra: Gene on new preprint from Lowy Lab, UC San Diego Health Moores Cancer Center
Insight
Jul 3, 2024, 03:24
Lumír Kunovský: Harvard University on management of pancreatic disorders for the practicing clinicians
Blog
Jul 3, 2024, 03:15
Partnership of HUG and the National Cancer Center of Mongolia to advance cancer care in Mongolia
Societies
Jul 3, 2024, 02:47
Seyed Alireza Javadinia: Oesophago-gastric cancer on the third day of ESMOGI24
Blog
Jul 3, 2024, 02:46
Malak Alharbi: Stephen V. Liu discusses treatment algorithm for early-stage NSCLC
Insight
Jul 3, 2024, 02:35
Rahul Banerjee: Fascinating small Ph2 trial on relapsed or refractory multiple myeloma
Blog
Jul 3, 2024, 02:27
Community distress and 'no shows' to CT screenings
Blog
Jul 3, 2024, 02:10
Mark Lewis: Mutism isn't a compassionate option either; silence can be mistaken for a figurative shrug of aloofness